Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1960 1
1988 1
1989 1
1990 2
1992 1
1993 1
1994 1
1995 7
1996 2
1997 3
1998 14
1999 5
2000 2
2001 2
2002 7
2003 3
2004 2
2005 6
2006 7
2007 7
2008 13
2009 7
2010 7
2011 8
2012 5
2013 4
2014 5
2015 11
2016 7
2017 5
2018 10
2019 10
2020 8
2021 8
2022 9
2023 7
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Comorbidities of COPD.
Cavaillès A, Brinchault-Rabin G, Dixmier A, Goupil F, Gut-Gobert C, Marchand-Adam S, Meurice JC, Morel H, Person-Tacnet C, Leroyer C, Diot P. Cavaillès A, et al. Among authors: leroyer c. Eur Respir Rev. 2013 Dec;22(130):454-75. doi: 10.1183/09059180.00008612. Eur Respir Rev. 2013. PMID: 24293462 Free PMC article. Review.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
Nair P, Wenzel S, Rabe KF, Bourdin A, Lugogo NL, Kuna P, Barker P, Sproule S, Ponnarambil S, Goldman M; ZONDA Trial Investigators. Nair P, et al. N Engl J Med. 2017 Jun 22;376(25):2448-2458. doi: 10.1056/NEJMoa1703501. Epub 2017 May 22. N Engl J Med. 2017. PMID: 28530840 Free article. Clinical Trial.
[Comorbidities of COPD].
Brinchault G, Diot P, Dixmier A, Goupil F, Guillais P, Gut-Gobert C, Leroyer C, Marchand-Adam S, Meurice JC, Morel H, Person C, Cavaillès A. Brinchault G, et al. Among authors: leroyer c. Rev Pneumol Clin. 2015 Dec;71(6):342-9. doi: 10.1016/j.pneumo.2015.09.009. Epub 2015 Nov 14. Rev Pneumol Clin. 2015. PMID: 26585876 Review. French.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Asthma and smoking: A review.
Kamga A, Rochefort-Morel C, Guen YL, Ouksel H, Pipet A, Leroyer C. Kamga A, et al. Among authors: leroyer c. Respir Med Res. 2022 Nov;82:100916. doi: 10.1016/j.resmer.2022.100916. Epub 2022 Jul 25. Respir Med Res. 2022. PMID: 35901579 Review.
[Patient expectations in asthma care].
Le Mao R, Tromeur C, Lacut K, Couturaud F, Foucaud J, Leroyer C. Le Mao R, et al. Among authors: leroyer c. Rev Mal Respir. 2021 May;38(5):514-523. doi: 10.1016/j.rmr.2021.03.003. Epub 2021 May 18. Rev Mal Respir. 2021. PMID: 34020836 Review. French.
[Plastic bronchitis].
Leroyer C, Couturaud F, Chenu E, Le Ber C, Petitet C, Eveilleau C, Clavier J. Leroyer C, et al. Rev Mal Respir. 1995;12(6):622-4. Rev Mal Respir. 1995. PMID: 8677357 French.
180 results